Support MEDICC and our global health equity projects.

Search

MEDICC Review journal features an exclusive interview with the Director of Clinical Research of Cuba’s Molecular Immunology Center, home to innovative cancer vaccines and therapies, including CIMAvax for non-small cell lung cancer, recently cleared for U.S. clinical trials.